Novo Nordisk Invests 327 Million Baht to Expand Clinical Research Facilities in Thailand
Novo Nordisk Pharma (Thailand) is investing 327 million baht to expand clinical trial facilities at Ramathibodi Hospital, aiming to boost international pharmaceutical research and establish Thailand as a regional hub.
Read up to 3 eligible full articles per Japan day (JST) for free
Create a free account to open up to 3 eligible full articles per Japan calendar day (JST). Headlines and summaries remain available across ASEAN 7.
Related articles
- Five Potential Health Benefits of Drinking Tea, From Heart Health to Better Focus
Tea, a beloved beverage in Thailand, contains compounds like polyphenols and L-theanine, offering potential health benefits such as reduced heart disease risk and improved focus. It is recommended as part of a balanced diet, not as a disease prevention or cure.
- Pattaya City Partners with Navy Hospitals to Enhance Healthcare Access
Pattaya City is collaborating with Queen Sirikit Naval Hospital and Abhakornkiatiwong Hospital to boost public awareness of medical services and benefits. This initiative aims to inform residents about available treatment options, enabling better access to healthcare and appropriate use of entitlements.
- Pattaya School Closes for Two Days After Student's Shooting Threat
Pattaya City School 3 in Naklua closed for two days after a Grade 7 student posted a shooting threat in a LINE group. Police and authorities are investigating the incident, which fortunately did not materialize, and students were safely dismissed.
- Thailand Plans Major Medical Park on Former Train Station Site
Thailand's Ministry of Transport and Siriraj Hospital are advancing plans to develop a large-scale Medical Park on approximately 21 rai (33,600 sqm) of land at the former Thonburi railway station in Bangkok. A joint committee has been established to design the area.